Insights

Tax tips, options trading ideas, and market takes — updated regularly.

filtered by tagclear

Market Commentary
Novo Nordisk Just Sued Eli Lilly Over Weight-Loss Drug Ads. Here's What That Means for Options Traders.

Novo Nordisk filed a federal lawsuit against Eli Lilly today alleging Lilly's GLP-1 drug ads use outdated data. The claims themselves are still just claims — but the filing is a real lesson in how options markets price a different kind of risk than an earnings date creates.

July 22, 2026